Top Markets
Coin of the day
Arno Therapeutics, Inc. Arno Therapeutics, Inc.

Arno Therapeutics, Inc.

ARNI
Rang in aandelen #42094
Arno Therapeutics, Inc., headquartered in Flemington, New Jersey, operates as a... Arno Therapeutics, Inc., headquartered in Flemington, New Jersey, operates as a biopharmaceutical enterprise focused on discovering and advancing treatments for cancer and other severe health conditions. The company's developmental portfolio includes several key compounds: Onapristone, a type 1 anti-progestin hormone blocker, is currently undergoing Phase I/II clinical trials. This therapeutic is being investigated for its efficacy in treating various solid tumors, such as breast and endometrial cancers in post-menopausal women, and advanced castration-resistant prostate cancer in men. AR-12, an orally administered cancer therapy, has successfully completed Phase I clinical studies for solid tumors and hematological malignancies. Additionally, it is in pre-clinical development for potential applications against a range of microbial targets. AR-42, another innovative oral cancer treatment, is involved in a Phase I investigator-initiated clinical study, targeting both hematological malignancies and solid tumors. To support its research and development efforts, Arno Therapeutics has established licensing agreements with Invivis Pharmaceuticals, Inc., the Regents of the University of Minnesota, and the Ohio State University Innovation Foundation. The company also holds a co-development partnership with Leica Biosystems Newcastle Ltd.
Aandeelprijs
$0.0001
Laatst gesynchroniseerd: 2026-08-11
Marktkapitalisatie
$4.94K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel Arno Therapeutics, Inc. (ARNI)

Categorie

Prijs ARNI met de marktkapitalisatie van B
Arno Therapeutics, Inc. Arno Therapeutics, Inc.
ARNI
$0.0001
Marktkapitalisatie van Arno Therapeutics, Inc.(ARNI)
Marktkapitalisatie: $4.94K
Vanaf August 2026 heeft Arno Therapeutics, Inc. een marktkapitalisatie van $4.94K. Dit maakt Arno Therapeutics, Inc. volgens onze gegevens het 42094th meest waardevolle bedrijf ter wereld op basis van marktkapitalisatie. De marktkapitalisatie is de totale marktwaarde van alle uitstaande aandelen van een beursgenoteerd bedrijf en wordt vaak gebruikt om de waarde van een bedrijf te meten.
Marktkapitalisatiegeschiedenis van Arno Therapeutics, Inc. van 2008 tot 2026
ARNI vergeleken met de top 5 populairste stocks
Prijs voor ARNI Aandeel B Marktkapitalisatie van B uitslagen
Arno Therapeutics, Inc. Arno Therapeutics, Inc.
$109,085 $4.94K
$5.383T +109,085,297,974.98%
Arno Therapeutics, Inc. Arno Therapeutics, Inc.
$89,633.05 $4.94K
$4.423T +89,633,053,673.82%
Arno Therapeutics, Inc. Arno Therapeutics, Inc.
$84,303.33 $4.94K
$4.160T +84,303,331,188.39%
Arno Therapeutics, Inc. Arno Therapeutics, Inc.
$74,231.43 $4.94K
$3.663T +74,231,425,168.49%
Arno Therapeutics, Inc. Arno Therapeutics, Inc.
$58,586.20 $4.94K
$2.891T +58,586,196,362.01%